ClearPoint Neuro, Inc. Debt Instrument, Increase (Decrease), Other, Net
ClearPoint Neuro, Inc. (CLPT) reported Debt Instrument, Increase (Decrease), Other, Net of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentIncreaseDecreaseOtherNet · last filed 2022-03-09
- ClearPoint Neuro, Inc. debt instrument, increase (decrease), other, net for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- ClearPoint Neuro, Inc. debt instrument, increase (decrease), other, net for fiscal 2020 was $896.00K.
| Period end | Debt Instrument, Increase (Decrease), Other, Net 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-09 |
| 2020-12-31 | $896.00K 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |